Intravenous cyclophosphamide pulse therapy in the treatment of systemic sclerosis-related interstitial lung disease: a long term study.

MLA

Simeón-Aznar, C. P., et al. “Intravenous Cyclophosphamide Pulse Therapy in the Treatment of Systemic Sclerosis-Related Interstitial Lung Disease: A Long Term Study.” The Open Respiratory Medicine Journal, vol. 2, 2008, pp. 39–45. EBSCOhost, https://doi.org/10.2174/1874306400802010039.

APA

Simeón-Aznar, C. P., Fonollosa-Plá, V., Tolosa-Vilella, C., Selva-O Callaghan, A., Solans-Laqué, R., Palliza, E., Muñoz, X., & Vilardell-Tarrés, M. (2008). Intravenous cyclophosphamide pulse therapy in the treatment of systemic sclerosis-related interstitial lung disease: a long term study. The Open Respiratory Medicine Journal, 2, 39–45. https://doi.org/10.2174/1874306400802010039

Chicago

Simeón-Aznar, C P, V Fonollosa-Plá, C Tolosa-Vilella, A Selva-O Callaghan, R Solans-Laqué, E Palliza, X Muñoz, and M Vilardell-Tarrés. 2008. “Intravenous Cyclophosphamide Pulse Therapy in the Treatment of Systemic Sclerosis-Related Interstitial Lung Disease: A Long Term Study.” The Open Respiratory Medicine Journal 2: 39–45. doi:10.2174/1874306400802010039.